DGAP-News: Geratherm Medical AG / Key word(s): Alliance Geratherm Medical AG: Cooperation between Philips and apoplex provides substantial improvement in stroke care 17.07.2013 / 09:55 --------------------------------------------------------------------- Corporate News Together Against Stroke Cooperation between Philips and apoplex medical provides substantial improvement in stroke care Hamburg / Pirmasens, July 17, 2013 - By automated merging of patient information, apoplex medical technolo>gies and Philips will take the next step in the battle against stroke. Particularly stroke patients with strokes of unknown origin could benefit from this. Undetected atrial fibrillation is considered to be a potential cause for stroke. Several methods for the detection of paroxysmal atrial fibrillation can help to confirm this assumption. With the fully automated ECG analysis for the detection of atrial fibrillation SRAclinic (SRA = Stroke Risk Analysis), developed by apoplex medical technologies, a method is now available, which is significantly superior to all previous standard methods. The ECG data for this analysis are provided for example by the patient monitoring system Philips IntelliVue. It records the patient data at the stroke unit and exports them pseudonymized at the touch of a button to the analysis server in the data center of apoplex medical technologies. There the data are analysed for paroxysmal atrial fibrillation (pxVHF) and summarized for the physician in a clearly arranged and expressive report. Based on this, a therapy with anticoagulants can be initiated, which reduces the risk for further strokes substantially. 'A retrospective output function, integrated in the Philips IntelliVue Monitoring System, enables the transfer of up to 96 hours long term ECGs without additional interface effort', explains Thomas Groß, Business Manager Patient Monitoring at Philips Healthcare Germany. This simplifies the clinical processes in a considerable extent. All stroke patients connected to a Philips Monitoring System are examined for atrial fibrillation during their complete bed time. There are no additional activities, neither for the physicians nor for the nursing staff, which could lead to further burden. As the data center of apoplex medical technologies is available to all hospitals, there are no additional technical requirements at the hospitals. For Albert Hirtz, General Manager at apoplex medical technologies, it is obvious that patients and the health system equally benefit from such prevention: 'each prevented stroke is a piece of luck for the people. And for the society it means a substantial reduction of costs in the end.' In Germany 250.000 people suffer from stroke each year. In 35 to 40 percent of these strokes, the origin is not detectable. . Further information to SRAclinic at: www.apoplexmedical.com Further information to IntelliVue Patient Monitoring at: www.philips.de About Royal Philips: Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 116,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter. About apoplex medical technologies apoplex medical technologies GmbH was founded in 2004 in Pirmasens, in the west of the Rhineland-Palatinate, and, within the field of medical technology, specializes in new and innovative technological products for the prevention of strokes throughout the world. The subsidiary of Geratherm Medical AG focuses on easily applicable and efficient methods of patient screening using medical-technical applications to prevent strokes and vascular dementia. The SRA (Stroke Risk Analysis) procedure is the first practicable screening method for paroxysmal atrial fibrillation. It is available in versions for use in medical practices and stroke units. apoplex medical technologies is supported by an extensive academic and clinical network, which professionally supplements its own core competences in the fields of mathematics, physics and medicine. Further information is available at www.apoplexmedical.com. apoplex medical technologies GmbH Albert Hirtz Delaware Avenue 1 - 3 D-66953 Pirmasens fon: +49/(0)6331/698998-0 fax: +49/(0)6331/698998-19 http://www.apoplexmedical.com [email protected] End of Corporate News --------------------------------------------------------------------- 17.07.2013 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Geratherm Medical AG Fahrenheitstraße 1 98716 Geschwenda Germany Phone: +49 (0)36205 98-0 Fax: +49 (0)36205 98-1 15 E-mail: [email protected] Internet: www.geratherm.com ISIN: DE0005495626 WKN: 549562 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 221568 17.07.2013